Back to Search Start Over

Consequences of low estimated glomerular filtration rate either before or early after kidney donation.

Authors :
Evans MD
Helgeson ES
Rule AD
Vock DM
Matas AJ
Source :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2024 Oct; Vol. 24 (10), pp. 1816-1827. Date of Electronic Publication: 2024 Jun 14.
Publication Year :
2024

Abstract

In the general population, decreases in glomerular filtration rate (GFR) are associated with subsequent development of chronic kidney disease (CKD), cardiovascular disease (CVD), and death. It is unknown if low estimated GFR (eGFR) before or early after kidney donation was also associated with these risks. One thousand six hundred ninety-nine living donors who had both predonation and early (4-10 weeks) postdonation eGFR were included. We studied the relationships between eGFR, age at donation, and the time to sustained eGFR<45 (CKD stage 3b) and <30 mL/min/1.73m <superscript>2</superscript> (CKD stage 4), hypertension, diabetes mellitus (DM), CVD, and death. Median follow-up was 12 (interquartile range, 6-21) years. Twenty-year event rates were 5.8% eGFR<45 mL/min/1.73m <superscript>2</superscript> ; 1.2% eGFR<30 mL/min/1.73m <superscript>2</superscript> ; 29.0% hypertension; 7.8% DM; 8.0% CVD; and 5.2% death. The median time to eGFR<45 mL/min/1.73m <superscript>2</superscript> (N = 79) was 17 years, and eGFR<30 mL/min/1.73m <superscript>2</superscript> (N = 22) was 25 years. Both low predonation and early postdonation eGFR were associated with eGFR<45 mL/min/1.73m <superscript>2</superscript> (P < .0001) and eGFR<30 mL/min/1.73m <superscript>2</superscript> (P < .006); however, the primary driver of risk for all ages was low postdonation (rather than predonation) eGFR. Predonation and postdonation eGFR were not associated with hypertension, DM, CVD, or death. Low predonation and early postdonation eGFR are risk factors for developing eGFR<45 mL/min/1.73m <superscript>2</superscript> (CKD stage 3b) and <30 mL/min/1.73m <superscript>2</superscript> (CKD stage 4), but not CVD, hypertension, DM, or death.<br />Competing Interests: Declaration of competing interest The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.<br /> (Copyright © 2024 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1600-6143
Volume :
24
Issue :
10
Database :
MEDLINE
Journal :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Publication Type :
Academic Journal
Accession number :
38878866
Full Text :
https://doi.org/10.1016/j.ajt.2024.04.023